Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target The Role of Microbiome in Cardiovascular Health: Insights for Primary Care Interventions Cureus Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota PDF] Trimethylamine N Oxide, the Microbiome, and Heart and Kidney Disease. Semantic Scholar Gut microbe derived metabolite trimethylamine N oxide activates PERK to drive fibrogenic mesenchymal differentiation: iScience Full article: Gutheart axis: emerging therapies targeting trimethylamine N oxide production